awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47972879-E0D01A29-B696-4F28-9EE2-67A9CEB95ED0
Q47972879-E0D01A29-B696-4F28-9EE2-67A9CEB95ED0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47972879-E0D01A29-B696-4F28-9EE2-67A9CEB95ED0
Direct Oral Anticoagulant Use in Atypical Thrombosis-Related Conditions.
P2860
Q47972879-E0D01A29-B696-4F28-9EE2-67A9CEB95ED0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47972879-E0D01A29-B696-4F28-9EE2-67A9CEB95ED0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a901a53a1a3961f92162070fa04f59055d44ed94
P2860
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.